Literature DB >> 15336378

Polymer microspheres for controlled drug release.

S Freiberg1, X X Zhu.   

Abstract

Polymer microspheres can be employed to deliver medication in a rate-controlled and sometimes targeted manner. Medication is released from a microsphere by drug leaching from the polymer or by degradation of the polymer matrix. Since the rate of drug release is controlled by these two factors, it is important to understand the physical and chemical properties of the releasing medium. This review presents the methods used in the preparation of microspheres from monomers or from linear polymers and discusses the physio-chemical properties that affect the formation, structure, and morphology of the spheres. Topics including the effects of molecular weight, blended spheres, crystallinity, drug distribution, porosity, and sphere size are discussed in relation to the characteristics of the release process. Added control over release profiles can be obtained by the employment of core-shell systems and pH-sensitive spheres; the enhancements presented by such systems are discussed through literature examples.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336378     DOI: 10.1016/j.ijpharm.2004.04.013

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  123 in total

1.  Solid-phase synthesis and kinetic characterization of fluorogenic enzyme-degradable hydrogel cross-linkers.

Authors:  Jason A Moss; Shula Stokols; Mark S Hixon; Fawn T Ashley; Jason Y Chang; Kim D Janda
Journal:  Biomacromolecules       Date:  2006-04       Impact factor: 6.988

2.  Formulation of anastrozole microparticles as biodegradable anticancer drug carriers.

Authors:  Ahmed S Zidan; Omaima A Sammour; Mohammed A Hammad; Nagia A Megrab; Muhammad D Hussain; Mansoor A Khan; Muhammad J Habib
Journal:  AAPS PharmSciTech       Date:  2006-07-21       Impact factor: 3.246

3.  Biocompatibility of polyhydroxybutyrate microspheres: in vitro and in vivo evaluation.

Authors:  Ekaterina Igorevna Shishatskaya; Olga N Voinova; Anastasiya V Goreva; Olga A Mogilnaya; Tatiana G Volova
Journal:  J Mater Sci Mater Med       Date:  2008-02-06       Impact factor: 3.896

4.  Bioactive microspheres produced from gelatin-siloxane hybrids for bone regeneration.

Authors:  Byung-Ho Yoon; Hyoun-Ee Kim; Hae-Won Kim
Journal:  J Mater Sci Mater Med       Date:  2007-12-12       Impact factor: 3.896

5.  Influence of the lipophilic external phase composition on the preparation and characterization of xylan microcapsules--a technical note.

Authors:  Toshiyuki Nagashima; Elquio Eleamen Oliveira; Acarília Eduardo da Silva; Henrique Rodrigues Marcelino; Monique Christine Salgado Gomes; Larissa Muratori Aguiar; Ivonete Batista de Araújo; Luiz Alberto Lira Soares; Anselmo Gomes de Oliveira; E Sócrates Tabosa do Egito
Journal:  AAPS PharmSciTech       Date:  2008-07-08       Impact factor: 3.246

Review 6.  Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction.

Authors:  Wei Chen; Bryant C Yung; Zhiyong Qian; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2018-01-31       Impact factor: 15.470

7.  Single Step Double-walled Nanoencapsulation (SSDN).

Authors:  Aharon Azagury; Vera C Fonseca; Daniel Y Cho; James Perez-Rogers; Christopher M Baker; Elaine Steranka; Victoria Goldenshtein; Dominick Calvao; Eric M Darling; Edith Mathiowitz
Journal:  J Control Release       Date:  2018-05-02       Impact factor: 9.776

8.  Formulation of salicylate-based poly(anhydride-ester) microspheres for short- and long-term salicylic acid delivery.

Authors:  Roselin Rosario-Meléndez; Michelle A Ouimet; Kathryn E Uhrich
Journal:  Polym Bull (Berl)       Date:  2012-09-07       Impact factor: 2.870

9.  Preparation of hydroxyapatite spheres with an internal cavity as a scaffold for hard tissue regeneration.

Authors:  Hae-Hyoung Lee; Seok-Jung Hong; Chul-Hwan Kim; Eun-Cheol Kim; Jun-Hyeog Jang; Hong-In Shin; Hae-Won Kim
Journal:  J Mater Sci Mater Med       Date:  2008-04-04       Impact factor: 3.896

10.  5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.

Authors:  Yuting Lin; Yan Li; Chui Ping Ooi
Journal:  J Mater Sci Mater Med       Date:  2012-07-29       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.